Skip to main content
Signal8
FORSYTH DOUGLAS profile photo

Douglas Forsyth

CIK: 0001240801

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Inhibrx Biosciences, Inc. logo
INBX

Inhibrx Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    Sep 8, 2026
    Purchase(P)
    Indirect
    2.5K shares at avg. $114.65$287K
  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    Jun 3, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    10K shares-
  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    May 28, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    15K shares-

1-3 of 3

About FORSYTH DOUGLAS

FORSYTH DOUGLAS (SEC CIK 0001240801) files insider reports with the SEC as Director of Inhibrx Biosciences, Inc. (INBX).

Signal8 holds 4 ownership filings by FORSYTH DOUGLAS, all Form 4s, filed between May 29, 2025 and Sep 18, 2026. Those filings report 3 transactions, from May 28, 2025 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on FORSYTH DOUGLAS's filings is in LA JOLLA, CA.

Recent filings by FORSYTH DOUGLAS

  • Sep 8, 2026: Open-market purchase of INBX shares (Form 4, code P).
  • Jun 3, 2026: Grant or award of INBX derivative securities (Form 4, code A).
  • May 28, 2025: Grant or award of INBX derivative securities (Form 4, code A).

Other insiders filing for Inhibrx Biosciences, Inc. (INBX)

How to read Form 4 transaction codes